NCT01602692View on ClinicalTrials.gov

A Comparison of Tumescence in Breast Reduction Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Pain, PostoperativePostoperative Nausea and Vomiting
Interventions
DRUG

Tumescent solution with dilute lidocaine and epinephrine

Tumescent Solution containing both dilute lidocaine (0.05%) and dilute epinephrine (1:1,000,000)

DRUG

Tumescent Solution with dilute epinephrine

Tumescent Solution containing dilute epinephrine (1:1,000,000) only

Trial Locations (1)

53562

University of Wisconsin Transformations Surgery Center, Middleton

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01602692 - A Comparison of Tumescence in Breast Reduction Surgery | Biotech Hunter | Biotech Hunter